Ogg1 null mice exhibit age-associated loss of the nigrostriatal pathway and increased sensitivity to MPTP

Neurochemistry International

Volumn 61, Issue 5, 2012, Pages 721-730

  Cardozo Pelaez, Fernando ^a,b   Sanchez Contreras, Monica ^a   Nevin, Andrew B C ^a  

^a UNIVERSITY OF MONTANA   (United States)

^b UNIVERSITY OF MONTANA   (United States)

Author keywords

7,8 Dihydroxy 2 deoxyguanine; Aging; DNA damage; DNA repair; MPTP; Ogg1; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 8 HYDROXYDEOXYGUANOSINE; 8 OXOGUANINE GLYCOSYLASE 1; DOPAMINE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; ROTENONE; TYROSINE 3 MONOOXYGENASE; UBIQUITIN; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL LOSS; CELL POPULATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOPAMINE BLOOD LEVEL; FEMALE; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; MOUSE STRAIN; NERVE CELL; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TOXICOLOGY; WILD TYPE;

AGING; ANIMALS; CORPUS STRIATUM; DNA GLYCOSYLASES; FEMALE; MALE; MICE; MICE, 129 STRAIN; MICE, KNOCKOUT; MPTP POISONING; NEURAL PATHWAYS; SUBSTANTIA NIGRA;

MUS; PARKINSONIA;

EID: 84866496709     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.06.013     Document Type: Article

References (58)

1. T. Abe, C. Isobe, T. Murata, C. Sato, and H. Tohgi Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease Neurosci. Lett. 336 2003 105 108
2. Z.I. Alam, A. Jenner, S.E. Daniel, A.J. Lees, N. Cairns, C.D. Marsden, P. Jenner, and B. Halliwell Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra J. Neurochem. 69 1997 1196 1203
3. A. Alves-Rodrigues, L. Gregori, and M.E. Figueiredo-Pereira Ubiquitin, cellular inclusions and their role in neurodegeneration Trends Neurosci. 21 1998 516 520
4. S. Beretta, J.P. Wood, B. Derham, G. Sala, L. Tremolizzo, C. Ferrarese, and N.N. Osborne Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) Neurobiol. Dis. 24 2006 308 317
5. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neurosci. 3 2000 1301 1306
6. C. Bolin, T. Stedeford, and F. Cardozo-Pelaez Single extraction protocol for the analysis of 8-hydroxy-2'-deoxyguanosine (oxo8dG) and the associated activity of 8-oxoguanine DNA glycosylase J. Neurosci. Methods 136f 2004 69 76
7. F. Cardozo-Pelaez, P.J. Brooks, T. Stedeford, S. Song, and J. Sanchez-Ramos DNA damage, repair, and antioxidant systems in brain regions: a correlative study Free Radic. Biol. Med. 28 2000 779 785
8. F. Cardozo-Pelaez, D.P. Cox, and C. Bolin Lack of the DNA repair enzyme OGG1 sensitizes dopamine neurons to manganese toxicity during development Gene Expr. 12 2005 315 323
9. F. Cardozo-Pelaez, S. Song, A. Parthasarathy, C. Hazzi, K. Naidu, and J. Sanchez-Ramos Oxidative DNA damage in the aging mouse brain Mov. Disord. 14 1999 972 980
10. L.J. Chen, Y.Q. Gao, X.J. Li, D.H. Shen, and F.Y. Sun Melatonin protects against MPTP/MPP+ -induced mitochondrial DNA oxidative damage in vivo and in vitro J. Pineal Res. 39 2005 34 42
11. C.C. Chiou, P.Y. Chang, E.C. Chan, T.L. Wu, K.C. Tsao, and J.T. Wu Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers Clin. Chim. Acta 334 2003 87 94
12. C.C. Chiueh, H. Miyake, and M.T. Peng Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism Adv. Neurol. 60 1993 251 258
13. W. Dauer, N. Kholodilov, M. Vila, A.C. Trillat, R. Goodchild, K.E. Larsen, R. Staal, K. Tieu, Y. Schmitz, C.A. Yuan, M. Rocha, V. Jackson-Lewis, S. Hersch, D. Sulzer, S. Przedborski, R. Burke, and R. Hen Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP Proc. Natl. Acad. Sci. USA 99 2002 14524 14529
14. P.D. de Lima, E.S. Yamada, E.T. da Costa, O. Pessoa Cdo, S.H. Rabenhorst, O. Bahia Mde, P.C. Cardoso, R.A. Santos, A. Smith Mde, and R.R. Burbano Genotoxic effects of rotenone on cultured lymphocytes Genet. Mol. Res. 4 2005 822 831
15. T.P. Devasagayam, S. Steenken, M.S. Obendorf, W.A. Schulz, and H. Sies Formation of 8-hydroxy(deoxy)guanosine and generation of strand breaks at guanine residues in DNA by singlet oxygen Biochemistry 30 1991 6283 6289
16. M. Dizdaroglu, P. Jaruga, M. Birincioglu, and H. Rodriguez Free radical-induced damage to DNA: mechanisms and measurement Free Radic. Biol. Med. 32 2002 1102 1115
17. B.A. Donzanti, and B.K. Yamamoto An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates Life Sci. 43 1988 913 922
18. S. Fahn, and G. Cohen The oxidant stress hypothesis in Parkinson's disease: evidence supporting it Ann. Neurol. 32 1992 804 812
19. E.C. Friedberg, and L.B. Meira Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage Version 7 DNA Repair (Amst) 5 2006 189 209
20. J. Fukae, Y. Mizuno, and N. Hattori Mitochondrial dysfunction in Parkinson's disease Mitochondrion 7 2007 58 62
21. B.I. Giasson, J.E. Duda, S.M. Quinn, B. Zhang, J.Q. Trojanowski, and V.M. Lee Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein Neuron 34 2002 521 533
22. W.R. Gibb, T. Scott, and A.J. Lees Neuronal inclusions of Parkinson's disease Mov. Disord. 6 1991 2 11
23. J.T. Greenamyre, R. Betarbet, and T.B. Sherer The rotenone model of Parkinson's disease: genes, environment and mitochondria Parkinsonism Relat. Disord. 9 Suppl 2 2003 S59 64
24. B. Halliwell, and J.M. Gutteridge Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts Arch. Biochem. Biophys. 246 1986 501 514
25. A. Klungland, I. Rosewell, S. Hollenbach, E. Larsen, G. Daly, B. Epe, E. Seeberg, T. Lindahl, and D.E. Barnes Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage Proc. Natl. Acad. Sci. USA 96 1999 13300 13305
26. R. Kruger, W. Kuhn, T. Muller, D. Woitalla, M. Graeber, S. Kosel, H. Przuntek, J.T. Epplen, L. Schols, and O. Riess Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nat. Genet. 18 1998 106 108
27. I.I. Kruman, R.P. Wersto, F. Cardozo-Pelaez, L. Smilenov, S.L. Chan, F.J. Chrest, R. Emokpae Jr., M. Gorospe, and M.P. Mattson Cell cycle activation linked to neuronal cell death initiated by DNA damage Neuron 41 2004 549 561
28. M. Lee, D. Hyun, B. Halliwell, and P. Jenner Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult J. Neurochem. 76 2001 998 1009
29. M.K. Lee, W. Stirling, Y. Xu, X. Xu, D. Qui, A.S. Mandir, T.M. Dawson, N.G. Copeland, N.A. Jenkins, and D.L. Price Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 - Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice Proc. Natl. Acad. Sci. USA 99 2002 8968 8973
30. D. Liu, D.L. Croteau, N. Souza-Pinto, M. Pitta, J. Tian, C. Wu, H. Jiang, K. Mustafa, G. Keijzers, V.A. Bohr, and M.P. Mattson Evidence that OGG1 glycosylase protects neurons against oxidative DNA damage and cell death under ischemic conditions 2011 J. Cereb. Blood Flow Metab.
31. D.G. MacMahon, and R. Bland Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline is effective and safe in early stages BMJ 312 1996 703
32. C. Mancuso, G. Scapagini, D. Curro, A.M. Giuffrida Stella, C. De Marco, D.A. Butterfield, and V. Calabrese Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders Front. Biosci. 12 2007 1107 1123
33. B.S. Mandavilli, S.F. Ali, and B. Van Houten DNA damage in brain mitochondria caused by aging and MPTP treatment Brain Res. 885 2000 45 52
34. L. Migliore, L. Petrozzi, C. Lucetti, G. Gambaccini, S. Bernardini, R. Scarpato, F. Trippi, R. Barale, G. Frenzilli, V. Rodilla, and U. Bonuccelli Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients Neurology 58 2002 1809 1815
35. J.R. Milligan, J.A. Aguilera, and J.F. Ward Redox equilibrium between guanyl radicals and thiocyanate influences base damage yields in gamma irradiated plasmid DNA. Estimation of the reduction potential of guanyl radicals in plasmid DNA in aqueous solution at physiological ionic strength Int. J. Radiat. Biol. 77 2001 1195 1205
36. O. Minowa, T. Arai, M. Hirano, Y. Monden, S. Nakai, M. Fukuda, M. Itoh, H. Takano, Y. Hippou, H. Aburatani, K. Masumura, T. Nohmi, S. Nishimura, and T. Noda Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice Proc. Natl. Acad. Sci. USA 97 2000 4156 4161
37. Y. Mizuno, S. Ohta, M. Tanaka, S. Takamiya, K. Suzuki, T. Sato, H. Oya, T. Ozawa, and Y. Kagawa Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease Biochem. Biophys. Res. Commun. 163 1989 1450 1455
38. Y. Nakabeppu, D. Tsuchimoto, H. Yamaguchi, and K. Sakumi Oxidative damage in nucleic acids and Parkinson's disease J. Neurosci. Res. 85 2007 919 934
39. M.C. Newland Animal models of manganese's neurotoxicity Neurotoxicology 20 1999 415 432
40. C.W. Olanow, J.H. Godbold, and W. Koller Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Patients taking selegeline may have received more levodopa than necessary BMJ 312 1996 702 703 author reply 704-705
41. P.L. Opresko, J. Fan, S. Danzy, D.M. Wilson 3rd, and V.A. Bohr Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2 Nucleic Acids Res. 33 2005 1230 1239
42. M. Osterod, S. Hollenbach, J.G. Hengstler, D.E. Barnes, T. Lindahl, and B. Epe Age-related and tissue-specific accumulation of oxidative DNA base damage in 7,8-dihydro-8-oxoguanine-DNA glycosylase (Ogg1) deficient mice Carcinogenesis 22 2001 1459 1463
43. B.A. Pappas, D. Zhang, C.M. Davidson, T. Crowder, G.A. Park, and T. Fortin Perinatal manganese exposure: behavioral, neurochemical, and histopathological effects in the rat Neurotoxicol. Teratol. 19 1997 17 25
44. L. Petrozzi, C. Lucetti, G. Gambaccini, S. Bernardini, P. Del Dotto, L. Migliore, R. Scarpato, and U. Bonuccelli Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients Neurol. Sci. 22 2001 83 84
45. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe, and R.L. Nussbaum Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
46. A.R. Proteggente, T.G. England, A. Rehman, C.A. Rice-Evans, and B. Halliwell Gender differences in steady-state levels of oxidative damage to DNA in healthy individuals Free Radic. Res. 36 2002 157 162
47. S. Przedborski, V. Jackson-Lewis, A.B. Naini, M. Jakowec, G. Petzinger, R. Miller, and M. Akram The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP): a technical review of its utility and safety J. Neurochem. 76 2001 1265 1274
48. J. Sanchez-Ramos, Eva Overvik, and B. Ames A marker of oxyradical-mediated DNA damage (8-hydroxy-2'-deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain Neurodegeneration 3 1994 197 204
49. S. Sato, Y. Mizuno, and N. Hattori Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease Neurology 64 2005 1081 1083
50. A.H. Schapira, J.M. Cooper, D. Dexter, P. Jenner, J.B. Clark, and C.D. Marsden Mitochondrial complex I deficiency in Parkinson's disease Lancet 1 1989 1269
51. C. Shao, S. Xiong, G.M. Li, L. Gu, G. Mao, W.R. Markesbery, and M.A. Lovell Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain Free Radic. Biol. Med. 45 2008 813 819
52. S. Steenken, and S. Jovanovic How easily oxidizable is DNA? One-electron reduction potentials of adenosine and guanosine radicals in aqueous solution J. Am. Chem. Soc. 119 1997 617 618
53. J.A. Stuart, B.M. Bourque, N.C. de Souza-Pinto, and V.A. Bohr No evidence of mitochondrial respiratory dysfunction in OGG1-null mice deficient in removal of 8-oxodeoxyguanine from mitochondrial DNA Free Radic. Biol. Med. 38 2005 737 745
54. K. Wakabayashi, S. Hayashi, A. Kakita, M. Yamada, Y. Toyoshima, M. Yoshimoto, and H. Takahashi Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy Acta Neuropathol. 96 1998 445 452
55. J. Wang, S. Xiong, C. Xie, W.R. Markesbery, and M.A. Lovell Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease J. Neurochem. 93 2005 953 962
56. A.W. Wong, G.P. McCallum, W. Jeng, and P.G. Wells Oxoguanine glycosylase 1 protects against methamphetamine-enhanced fetal brain oxidative DNA damage and neurodevelopmental deficits J. Neurosci. 28 2008 9047 9054
57. H. Yamaguchi, K. Kajitani, Y. Dan, M. Furuichi, M. Ohno, K. Sakumi, D. Kang, and Y. Nakabeppu MTH1, an oxidized purine nucleoside triphosphatase, protects the dopamine neurons from oxidative damage in nucleic acids caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Cell Death Differ. 13 2006 551 563
58. J. Zhang, G. Perry, M.A. Smith, D. Robertson, S.J. Olson, D.G. Graham, and T.J. Montine Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons Am. J. Pathol. 154 1999 1423 1429